Kenyan Online Pharmacy MYDAWA Raises New Round of Funding
MYDAWA, the Kenyan digital health platform, has secured a new funding round to expand its services across East Africa. The $9.6 million (~KES 1.3 billion) capital injection was led by IFU, Alta Semper, AAIC Investment, Creadev and Ohara Pharmaceutical Co.
Founded in 2017, MYDAWA is a technology-driven digital health company delivering holistic healthcare solutions across Kenya and Uganda. Its integrated platform offers online doctor consultations, lab testing, e-prescriptions, chronic-care management and medication delivery.
“The calibre of investors joining this round speaks for itself,” said Neil O’Leary, MYDAWA Founder. “It confirms that MYDAWA is not just solving real problems at scale—it’s building a blueprint for the future of healthcare in Africa. We’re honoured to have partners who share our vision and will help us accelerate our mission.”
MYDAWA plans to use the new funding to scale its “Bricks-and-Clicks Super Pharmacy” model across new markets, and enhance chronic-disease support programmes for patients who need regular, affordable care, It also plans to integrate AI-driven features to streamline service delivery, optimise inventory management, and ultimately reduce costs for patients.
“As MYDAWA’s long-term partner, we’ve witnessed firsthand the company’s ability to deliver transformative healthcare solutions at scale,” said Zach Fond, Partner at Alta Semper. “We’re excited to see this next phase of growth, which reinforces MYDAWA’s position as a category leader and a blueprint for digital health innovation across Africa.”
A landmark move in this expansion was the recent acquisition of Rocket Health Uganda, a leading telehealth provider, significantly expanding MYDAWA’s footprint and capabilities in Uganda. This investment will further drive regional expansion and widescale upgrades to the platform.
In 2024 alone, MYDAWA says it served over 1.8 million patients and enrolled more than 5,000 chronic-disease patients in its care programmes. Its “Mzima” programme in Kenya and “Bulunji” programme in Uganda exemplify the company’s commitment to comprehensive, accessible healthcare solutions. Meanwhile, its PrEP and PEP initiatives—funded by the Gates Foundation—support some 3,200 patients in prevention and early treatment. Strategic partnerships with hospitals, clinics, insurers, supermarkets, and pharmaceutical companies such as Novo Nordisk further amplify MYDAWA’s reach and impact.
“This investment marks a pivotal step towards realising MYDAWA’s vision of a digitally empowered, accessible and customer-centric healthcare ecosystem for every East African. Through this investment, we are positioned to deliver on the vision faster and more effectively than ever,” concludes MYDAWA COO, Priscilla Muhiu.
Follow us on WhatsApp, Telegram, Twitter, and Facebook, or subscribe to our weekly newsletter to ensure you don’t miss out on any future updates. Send tips to editorial@techtrendsmedia.co.ke
